PL2931256T3 - Emulsja zawierająca nieżywotną substancję medyczną - Google Patents

Emulsja zawierająca nieżywotną substancję medyczną

Info

Publication number
PL2931256T3
PL2931256T3 PL13817905T PL13817905T PL2931256T3 PL 2931256 T3 PL2931256 T3 PL 2931256T3 PL 13817905 T PL13817905 T PL 13817905T PL 13817905 T PL13817905 T PL 13817905T PL 2931256 T3 PL2931256 T3 PL 2931256T3
Authority
PL
Poland
Prior art keywords
emulsion containing
medicinal substance
live
live medicinal
substance
Prior art date
Application number
PL13817905T
Other languages
English (en)
Inventor
Erwin Mombarg
Theodorus Jansen
Henricus Johannes Maria Jagt
Original Assignee
Intervet International B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International B.V. filed Critical Intervet International B.V.
Publication of PL2931256T3 publication Critical patent/PL2931256T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17Newcastle disease virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/215Coronaviridae, e.g. avian infectious bronchitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18111Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL13817905T 2012-12-14 2013-12-13 Emulsja zawierająca nieżywotną substancję medyczną PL2931256T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12197191 2012-12-14
EP13817905.6A EP2931256B1 (en) 2012-12-14 2013-12-13 An emulsion containing a non-live medicinal substance

Publications (1)

Publication Number Publication Date
PL2931256T3 true PL2931256T3 (pl) 2017-07-31

Family

ID=47355919

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13817905T PL2931256T3 (pl) 2012-12-14 2013-12-13 Emulsja zawierająca nieżywotną substancję medyczną

Country Status (10)

Country Link
US (1) US9492548B2 (pl)
EP (1) EP2931256B1 (pl)
CN (1) CN104884042A (pl)
BR (1) BR112015013273A2 (pl)
ES (1) ES2599629T3 (pl)
HU (1) HUE031130T2 (pl)
MX (1) MX360271B (pl)
PL (1) PL2931256T3 (pl)
RU (1) RU2015128294A (pl)
WO (1) WO2014090975A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12246090B2 (en) 2018-10-16 2025-03-11 Intervet Inc. Stable emulsions of bacterial antigens

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0073856A1 (en) * 1981-08-28 1983-03-16 Gist-Brocades N.V. Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines, process for preventing infectious bronchitis and infectious-bronchitis virus strain
WO1992007552A1 (fr) 1990-11-06 1992-05-14 Nippon Shinyaku Co., Ltd. Preparation lyophilisee et sa production
JPH06157294A (ja) 1992-11-19 1994-06-03 Tanabe Seiyaku Co Ltd 脂肪微粒子製剤
CA2192773C (en) * 1995-12-15 2008-09-23 Hiroaki Okada Production of sustained-release preparation for injection
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
ES2538486T3 (es) 2002-09-12 2015-06-22 International Institute Of Cancer Immunology, Inc. Preparación de péptidos antigénicos contra el cáncer
CN101117627B (zh) * 2007-02-01 2010-07-14 中国农业科学院哈尔滨兽医研究所 猪流行性腹泻病毒弱毒疫苗株及其应用
CN101716150B (zh) * 2009-12-31 2011-06-22 刘静涵 关附甲素冻干乳剂及其制备方法
EP2462950A1 (en) 2010-12-08 2012-06-13 Neovacs Strongly inactivated and still highly immunogenic vaccine, and process of manufacturing thereof

Also Published As

Publication number Publication date
US20140170185A1 (en) 2014-06-19
HUE031130T2 (en) 2017-07-28
ES2599629T3 (es) 2017-02-02
EP2931256B1 (en) 2016-08-31
MX360271B (es) 2018-10-26
WO2014090975A1 (en) 2014-06-19
CN104884042A (zh) 2015-09-02
US9492548B2 (en) 2016-11-15
RU2015128294A (ru) 2017-01-19
EP2931256A1 (en) 2015-10-21
MX2015007579A (es) 2015-10-22
BR112015013273A2 (pt) 2017-07-11

Similar Documents

Publication Publication Date Title
IL233759A0 (en) Emulsion containing hormones
GB201322602D0 (en) Pharmaceutical compounds
GB201306610D0 (en) Pharmaceutical compounds
CR20140284A (es) Dispositivo de inhalación para fármacos en polvo
ZA201602047B (en) Pharmaceutical compounds
GB201205164D0 (en) Pharmaceutical compounds
GB201208910D0 (en) Emulsion
ZA201600027B (en) Pharmaceutical preparation
EP2921163A4 (en) OIL-IN-WATER EMULSION COMPOUND
EP2829263A4 (en) OIL EMULSION COMPOSITION IN WATER
IL233350A0 (en) Inhalation device for powdered drugs
GB201312386D0 (en) Pharmaceutical compounds
IL239512A0 (en) Pharmaceutical compounds
GB201202027D0 (en) Pharmaceutical compounds
PL2931256T3 (pl) Emulsja zawierająca nieżywotną substancję medyczną
SG11201406097SA (en) Capsule formulation
ZA201406407B (en) Pharmaceutical formulation containing flupirtin
PL2922571T3 (pl) Postać farmaceutyczna zawierająca metaloporfiryny zawierające karboran
GB201317166D0 (en) Pharmaceutical compounds
IL237221A0 (en) Analogues of phospholipid drugs
HUP1200066A2 (en) Tube foil for pharmaceutical use
ZA201506465B (en) Pharmaceutical preparation
GB201218499D0 (en) Film wing
GB201219236D0 (en) Pharmaceutical compounds
GB201214121D0 (en) Pharmaceutical compounds